
Senseonics Holdings, Inc.
Nasdaq · Industrial Instruments For Measurement, Display, and Control
Company Overview
A concise company profile alongside the latest public filing activity.
Senseonics Holdings develops implantable continuous glucose monitoring systems for people with diabetes, marketed under the Eversense brand. Its sensors are inserted under the skin and transmit glucose readings to a wearable device via a smart transmitter and mobile app.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| ROEDER DOUGLAS AInsider | Buy | $125K | 13,953.284at $8.98 | Aug 19, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable SENS activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.